RHOA and chronic myelogenous leukemia, BCR-ABL1 positive: Marroncini found that low extracellular Na+ could activate the RhoA/ROCK signaling pathway, leading to actin cytoskeleton rearrangements, thereby elevating proliferation, migration, and invasion of chronic myeloid leukemia (CML) cells in vitro [25].